Roche vs Samsung: Founders, CEOs and History
Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker. Samsung was founded in 1969 by Lee Byung-chul and is led by Jun Young-hyun and Roh Tae-moon.
Company facts
Founders
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
Samsung
Lee Byung-chul
Lee Byung-chul founded Samsung Sanghoe in Daegu in 1938, trading dried fish, produce and noodles.
CEOs and their tenures
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Samsung
- Jong-Hee Han2022–2025
Vice Chairman and CEO
A longtime TV business leader who helped keep Samsung the top global TV brand. He died suddenly in March 2025 while in office.
Source - Jay Y. Lee2022–present
Executive Chairman
Grandson of the founder and son of Lee Kun-hee. He was convicted in the 2017 bribery case and pardoned in 2022, and became Executive Chairman in October 2022. In 2025 the Supreme Court upheld his acquittal in the separate merger and accounting fraud case.
Source - Jun Young-hyun2024–present
Vice Chairman, Co-Chief Executive Officer, Head of Device Solutions
He implemented a complete overhaul of the semiconductor division's engineering processes, issuing a rare public apology in 2024 for the company's technological delays.
Source - Roh Tae-moon (TM Roh)2025–present
Co-Chief Executive Officer, Head of Device eXperience
As head of the MX (Mobile eXperience) division, he heavily integrated AI features (Galaxy AI) into the S-series flagship phones to combat Apple's dominance in the premium tier.
Source
Timeline: Roche and Samsung side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1938Samsung
Samsung Group begins
Lee Byung-chul founded Samsung as a trading company before later generations expanded the group into electronics and industry.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
1969Samsung
Samsung Electronics established
Samsung Electronics Industry Co. Ltd. was established as the group entered electronics manufacturing.
1977Samsung
Korea Semiconductor acquired
Samsung acquired Korea Semiconductor, a key step toward memory and component manufacturing leadership.
1993Samsung
New Management initiative
Lee Kun-hee launched the New Management push to raise quality, design, and global competitiveness.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2017Samsung
Harman acquisition closes
Samsung completed the Harman acquisition, expanding into connected car systems and premium audio.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2022Samsung
Jong-Hee Han becomes CEO
Jong-Hee Han became CEO of Samsung Electronics Co. in 2022. A longtime TV business leader who helped keep Samsung the top global TV brand.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2024Samsung
Jun Young-hyun becomes CEO
Jun Young-hyun became CEO of Samsung Electronics Co. in 2024. Head of the semiconductor (Device Solutions) division and memory business; sole CEO for part of 2025 after Han Jong-hee's death, then co-CEO with TM Roh from November 2025.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2025Samsung
TM Roh joins Young Hyun Jun as co-CEO
Samsung named TM Roh Head of Device eXperience and CEO, joining Young Hyun Jun as co-CEO.
2025Samsung
Annual revenue reaches ~$237B (KRW 333.6T)
Samsung Electronics reported ~$237 billion (KRW 333.6 trillion) in 2025 annual revenue and ~$31 billion (KRW 43.6 trillion) in operating profit.
2025Samsung
Roh Tae-moon (TM Roh) becomes CEO
Roh Tae-moon (TM Roh) became CEO of Samsung Electronics Co. in 2025. Longtime head of the mobile business.
Acquisitions
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Samsung
- FlaktGroup2025$1.7B
- Xealth2025Undisclosed
- Harman International2017$8B
- SmartThings2014$200M
Questions about Roche vs Samsung
Who is the CEO of F. Hoffmann-La Roche AG and Samsung Electronics Co., Ltd.?
F. Hoffmann-La Roche AG is led by Thomas Schinecker and Samsung Electronics Co., Ltd. is led by Jun Young-hyun and Roh Tae-moon. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was F. Hoffmann-La Roche AG founded vs Samsung Electronics Co., Ltd.?
F. Hoffmann-La Roche AG was founded in 1896 — 73 years before Samsung Electronics Co., Ltd., which was founded in 1969. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Samsung Electronics Co., Ltd..
How many employees does F. Hoffmann-La Roche AG have compared to Samsung Electronics Co., Ltd.?
F. Hoffmann-La Roche AG employs approximately 112,774 people, while Samsung Electronics Co., Ltd. employs approximately 259,149. Samsung Electronics Co., Ltd. has the larger workforce at 259,149 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are F. Hoffmann-La Roche AG and Samsung Electronics Co., Ltd. headquartered?
F. Hoffmann-La Roche AG is headquartered in Switzerland and Samsung Electronics Co., Ltd. is headquartered in South Korea. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded F. Hoffmann-La Roche AG and Samsung Electronics Co., Ltd.?
F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche. Samsung Electronics Co., Ltd. was founded by Lee Byung-chul.
Which company has a longer operating history — F. Hoffmann-La Roche AG or Samsung Electronics Co., Ltd.?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Samsung Electronics Co., Ltd. has been in operation for around 57 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Roche vs Samsung overview